Showing results (711-720 of 787) with videos related to
Sort By:
Pageof 79
Clinical Proteomics|August 29, 2023
Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosisDorsa Sohaei, Simon Thebault, Lisa M Avery, et al.Molecular & Cellular Proteomics : MCP|February 28, 2013
Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progressionPunit Saraon, Daniela Cretu, Natasha Musrap, et al.European Journal of Cancer (Oxford, England : 1990)|March 27, 2001
IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survivalD Katsaros, H Yu, M A Levesque, et al.Cancer Research|July 23, 2003
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancerGeorge M Yousef, Mary-Ellen Polymeris, Linda Grass, et al.Neuroscience Letters|May 26, 2020
Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's diseaseBryant Lim, Christopher Fowler, Qiao-Xin Li, et al.Clinical Chemistry|June 18, 2005
Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluidsChristina V Obiezu, Shannon J C Shan, Antoninus Soosaipillai, et al.Molecular Oncology|November 26, 2013
Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludinGeorge S Karagiannis, David F Schaeffer, Chan-Kyung J Cho, et al.Biological Chemistry|April 22, 2005
Enzymatic profiling of human kallikrein 14 using phage-display substrate technologyLoyse M Felber, Carla A Borgoño, Sylvain M Cloutier, et al.Molecular & Cellular Proteomics : MCP|June 27, 2013
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissuesHari Kosanam, Ioannis Prassas, Caitlin C Chrystoja, et al.Plos One|May 27, 2020
Urinary proteomics links keratan sulfate degradation and lysosomal enzymes to early type 1 diabetesJulie A D Van, Sergi Clotet-Freixas, Anne-Christin Hauschild, et al.Pageof 79